推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

[HTML] from hematologylibrary.orgK Hu, J Yu, K Suknuntha, S Tian… - …, 2011 - bloodjournal.hematologylibrary.org
Reprogramming blood cells to induced pluripotent stem cells (iPSCs) provides a novel tool for
modeling blood diseases in vitro. However, the well-known limitations of current reprogramming
technologies include low efficiency, slow kinetics, and transgene integration and residual ...
Cited by 6 - Related articles - All 3 versions
[HTML] from hematologylibrary.orgJ Sumegi, MG Barnes, SV Nestheide… - …, 2011 - bloodjournal.hematologylibrary.org
Familial hemophagocytic lymphohistiocytosis (FHL) is a rare, genetically heterogeneous autosomal
recessive immune disorder that results when the critical regulatory pathways that mediate immune
defense mechanisms and the natural termination of immune/inflammatory responses are ...
Cited by 4 - Related articles - All 2 versions
[HTML] from hematologylibrary.orgCG Brunstein, JS Miller, Q Cao… - …, 2011 - bloodjournal.hematologylibrary.org
Acute graft-versus-host disease (aGVHD) is associated with high risk of morbidity and mortality
and is a common complication after double umbilical cord blood (UCB) transplantation. To reduce
these risks, we established a method of CD4 + CD25 + FoxP3 + T regulatory cell (Treg) ...
Cited by 24 - Related articles - All 6 versions
[HTML] from hematologylibrary.orgS Avery, W Shi, M Lubin… - …, 2011 - bloodjournal.hematologylibrary.org
The influence of cell dose and human leukocyte antigen (HLA) match on double-unit cord blood
(CB) engraftment is not established. Therefore, we analyzed the impact of cell dose and
high-resolution HLA match on neutrophil engraftment in 84 double-unit CB transplant ...
Cited by 3 - Related articles - All 3 versions
[HTML] from hematologylibrary.orgML Hulbert, RC McKinstry, JAL Lacey… - …, 2011 - bloodjournal.hematologylibrary.org
Children with sickle cell disease (SCD) and strokes receive blood transfusion therapy for secondary
stroke prevention; despite this, approximately 20% experience second overt strokes. Given this
rate of second overt strokes and the clinical significance of silent cerebral infarcts, we ...
Cited by 7 - Related articles - All 4 versions

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

© 2010-2024 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室